skip to Main Content

Dr. Guerriero is Awarded a Terri Brodeur Breast Cancer Fellowship

Modulating the immune system as an anti-cancer strategy has shown great promise in some types of cancer, however there has…

read more

Drs. Shapiro and Guerriero Publish Key Findings on the Role of PARP Inhibitors in TNBC

This work demonstrates cross-talk between PARP inhibition and the tumor microenvironment related to STING/TBK1/IRF3 pathway activation in cancer cells that…

read more

Dr. Guerriero’s Interview on Targeting Macrophages in Breast Tumors.

read more
Back To Top